Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study.
Abushamat LA, Schauer IE, Low Wang CC, Mitchell S, Herlache L, Bridenstine M, Durbin R, Snell-Bergeon JK, Regensteiner JG, Reusch JE. Abushamat LA, et al. Among authors: mitchell s. J Investig Med. 2024 Mar;72(3):294-304. doi: 10.1177/10815589231225183. Epub 2024 Jan 18. J Investig Med. 2024. PMID: 38148342 Free article. Clinical Trial.
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial.
Gerstein HC, Ratner RE, Cannon CP, Serruys PW, García-García HM, van Es GA, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW; APPROACH Study Group. Gerstein HC, et al. Circulation. 2010 Mar 16;121(10):1176-87. doi: 10.1161/CIRCULATIONAHA.109.881003. Epub 2010 Mar 1. Circulation. 2010. PMID: 20194881 Clinical Trial.
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy Discontinuation.
Bhatt NS, Harris AC, Gorfinkel L, Ibanez K, Tkaczyk ER, Mitchell SA, Albuquerque S, Schechter T, Pavletic S, Duncan CN, Rotz SJ, Williams K, Carpenter PA, Cuvelier GDE. Bhatt NS, et al. Among authors: mitchell sa. Transplant Cell Ther. 2024 Dec 17:S2666-6367(24)00812-1. doi: 10.1016/j.jtct.2024.12.011. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39701289
Roadmap for Global Youth Substance Use Prevention, Screening, and Early Intervention Research.
Metz VE, Bendtsen M, Arya S, Francis JM, Ghosh A, Haller DM, Harris SK, Hinman A, Kline-Simon AH, Levy S, McPherson TL, Mitchell SG, Newbury-Birch D, Praharaj SK, Toner P, Weitzman ER, Sterling SA. Metz VE, et al. Among authors: mitchell sg. J Adolesc Health. 2025 Jan;76(1):9-15. doi: 10.1016/j.jadohealth.2024.09.023. J Adolesc Health. 2025. PMID: 39694600 No abstract available.
4,109 results